Today: 11 June 2026
Browse Category

Stock Market 17 October 2025

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue shares plunged 13% Thursday to a record low near $14 after news of U.K. lawsuits over Johnson’s Baby Powder, representing 3,000 claimants and potential £1 billion in damages. The stock is down about 34% year-to-date and nearly 40% below its IPO price. Wall Street cut price targets and Moody’s downgraded its outlook to “negative.” Kenvue’s market cap now stands at roughly $30–31 billion.
17 October 2025
···
Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda Corp. shares surged 36% in after-hours trading on Oct. 16 after announcing plans to build or acquire up to 20 cellular towers in Mexico by end-2025. The stock jumped from $2.23 to $2.85 overnight, driven by the company's tiny float of under 730,000 shares. Akanda pivoted to telecom infrastructure after merging with First Towers & Fiber in August 2025. Market cap remains below $2 million.
17 October 2025
·
Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies Financial Group shares dropped over 10% on Oct. 16 to $48.80, extending a month-to-date loss of about 25% after revealing $715 million in exposure to bankrupt First Brands Group. Multiple law firms launched probes into possible investor misstatements. Executives insist losses are manageable and called the selloff “overdone.” The decline came as other U.S. banks reported credit issues, fueling sector-wide concerns.
17 October 2025
··
Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Safe & Green Holdings regained Nasdaq compliance on Oct. 3, 2025, after a 1-for-64 reverse split and restructuring a financing deal. Shares surged 86.7% to $6.03 before retreating to $3. Executives took Q3 pay in stock, and the company is moving operations to a new Texas facility. FY2024 revenue fell to $4.98 million, with a net loss of $16.98 million; market cap stands at $1.5 million.
17 October 2025
···
$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

Zions Bancorp reported a $50 million loan loss tied to alleged fraud, sending its shares down 13% on October 16. Western Alliance stock fell 11% after filing a related fraud lawsuit. The news erased over $100 billion from U.S. bank stocks, dragging the KBW Regional Banking Index down 5–6% and major indexes lower. European bank shares also tumbled, with Germany’s DAX dropping below 24,000.
17 October 2025
····
Deutsche Bank Stock Plunges Again as Global Credit Jitters Flare – What Experts Predict Next

Deutsche Bank Stock Plunges Again as Global Credit Jitters Flare – What Experts Predict Next

Deutsche Bank shares fell about 6% to €28.60 on Friday, among the worst DAX performers as the index dropped 2% amid global market turmoil. The sell-off followed surprise loan losses and alleged fraud at two U.S. regional banks, sparking fears of wider credit stress. European bank stocks slid roughly 3%, with Barclays also down over 5%. Gold surged to a record above $4,378/oz as investors sought safe havens.
17 October 2025
·
Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Carbon Revolution faces possible Nasdaq delisting after failing equity and filing requirements, with deadlines set for late 2025. CREV shares traded at $3.73 on Oct. 17, 2025, down over 70% from their 52-week high, valuing the company under $7 million. Fiscal 2024 revenue hit a record $47.3 million, but net loss reached $146.4 million. The company warned it needs more funding within a quarter to remain solvent.
17 October 2025
··
Credit ‘Cockroach’ Jitters Shake Markets: Stocks Slide Globally as Gold Hits Record High

Credit ‘Cockroach’ Jitters Shake Markets: Stocks Slide Globally as Gold Hits Record High

Global stocks tumbled Thursday as fresh U.S. regional bank troubles triggered a worldwide selloff. The Dow fell 410 points, while Zions Bancorp and Western Alliance shares dropped 10% after disclosing bad loans and alleged fraud. Gold hit a record $4,378/oz as investors rushed to safe havens. Europe’s bank index slid 2.7%, and major Asian markets closed sharply lower.
17 October 2025
·······
Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Over $100 billion in U.S. bank market value was erased Thursday as the Dow fell nearly 400 points and the KBW Regional Banking Index dropped 6%. Zions Bancorp and Western Alliance plunged after disclosing fraud-related loan losses, sparking broad financial sector selloffs. Gold hit a record above $4,370/oz and Treasury yields slid as investors fled to safe havens. Wall Street leaders warned of wider credit risks.
17 October 2025
···
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics shares surged nearly 100% in after-hours trading Oct. 16 after the FDA granted Fast Track status to its AlloNK cell therapy for refractory rheumatoid arthritis. The stock jumped from a $2.77 close to as high as $6.33. Over 20 patients have received AlloNK in trials, with key safety and mechanistic data expected by mid-November. Artiva plans to begin a pivotal Phase 3 trial in 2026, pending results.
17 October 2025
·
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist Financial reported Q3 earnings of $1.04 per share, beating estimates, with net income rising to $1.35 billion on $5.24 billion revenue. Shares jumped 4% after results but remain down 5.3% year-to-date. Fee income surged 11% sequentially, offsetting flat net interest income. The bank maintained its $0.52 dividend and repurchased $500 million in stock.
17 October 2025
···
Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

Reliance Q2 Results Boost Investor Hopes – Double-Digit Growth, Jio IPO Buzz & Stock Breakout?

Reliance Industries is expected to report Q2 FY26 net profit of ₹18,000–21,000 crore, up about 10% year-on-year, with revenue rising to ₹2.52–2.57 lakh crore. The gains are driven by strong oil-to-chemicals margins and growth in Jio and retail. The stock has rebounded 4% in October after a post-Q1 drop. Investors await updates on a potential Jio IPO and progress in new energy and AI initiatives.
17 October 2025
····
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Surges on Obesity Drug Boom and Alzheimer’s Breakthroughs – Is $1,000 Next?

Eli Lilly shares hit a record $832 intraday on Oct. 1, fueled by demand for its obesity drugs and Alzheimer’s advances, before slipping 4% after Donald Trump pledged to cut weight-loss drug prices. Lilly’s Mounjaro and ZepBound now hold 57% of U.S. GLP-1 prescriptions, outpacing Novo Nordisk. First-half 2025 revenue jumped about 40% year-on-year. Most analysts remain bullish, despite valuation and policy concerns.
17 October 2025
··
Bank of America (BAC) Stock Soars on Earnings Beat – Can It Keep Climbing?

Bank of America (BAC) Stock Soars on Earnings Beat – Can It Keep Climbing?

Bank of America shares traded near $50 midday Friday, down about 1.5% after a 3.5% drop Thursday erased post-earnings gains. The bank reported Q3 net income of $8.5 billion and revenue of $28.1 billion, both above estimates. BAC raised its Q4 net interest income outlook and boosted its dividend. Analyst price targets rose after earnings, with the average 12-month target at $56.
17 October 2025
··
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir (PLTR) Stock Soars 300% on AI Mega-Deals – Boom or Bubble Ahead?

Palantir shares traded near $178–$180 on October 17, 2025, up 300% year-to-date and just below August’s record high. The surge follows major AI contracts, including a $10 billion U.S. Army deal and a new partnership with Snowflake. Q2 revenue rose 48% to $1.03 billion, with profit at $327 million. At $180 per share, Palantir’s valuation exceeds $425 billion, drawing both bullish targets and warnings of a bubble.
17 October 2025
···
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi shares surged 230% over the past year, hitting a 52-week high of $30.30 in late September before dropping to $26.60 on Oct. 16. The company will report Q3 earnings on Oct. 28, with analysts expecting EPS of $0.08 on $880 million in revenue. SoFi recently launched fee-free options trading and an AI-focused ETF, and plans to enable crypto payments by late 2025. CEO changes and student loan policy developments are also in focus.
17 October 2025
··
INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

INVO Fertility (IVF) Stock’s Wild 90% Surge Amid IVF Boom – What’s Behind the Frenzy?

INVO Fertility shares jumped nearly 90% to $1.43 on Oct. 16, 2025, with volume topping 108 million amid a sector rally sparked by White House plans to expand IVF access. The stock briefly surpassed $2 before dropping about 30% early the next day as traders took profits. INVO raised $200,000 in a preferred share sale and filed to register 8.35 million shares for resale. The company remains unprofitable and cash-strapped.
17 October 2025
·
1 … 1,474 1,475 1,476 1,477 1,478 … 1,540

Stock Market Today

  • Soybeans Extend Gains Amid Anticipation of USDA Export Sales and WASDE Reports
    June 10, 2026, 7:58 PM EDT. Soybeans held onto Wednesday's price gains, rising 4 to 9 ¼ cents with the national average cash price hitting $10.68 1/2. Soymeal futures showed mixed results, mostly down by $1.40 to $1, while soy oil futures advanced 33 to 55 points. Traders await the USDA's weekly Export Sales update and the World Agricultural Supply and Demand Estimates (WASDE) report on Thursday. Estimates predict steady old crop bean carryout and stable production outlooks for Brazil and Argentina. July and August soybean futures closed higher, reflecting cautious optimism ahead of key agricultural supply data releases.

Latest articles

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Lloyds stock drifts lower as FCA car finance hold clouds buyback hopes

Lloyds stock drifts lower as FCA car finance hold clouds buyback hopes

11 June 2026
Lloyds shares fell 0.98% as the FCA told Parliament that motor-finance compensation payments are now unlikely before 2027 due to legal challenges, prolonging uncertainty over redress costs and capital returns; investors must wait for clarity, with the next key update due July 30.
Go toTop